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Localized scleroderma: assessment of the therapeutic
 response to phototherapy *
Esclerodermia cutânea: avaliação da resposta terapêutica  à fototerapia
Roberta Buense1 Ida Alzira Gomes Duarte2
Marcio Bouer3
Abstract: BACKGROUND: Scleroderma is a chronic autoimmune disease characterized by progressive connective tissue
sclerosis and microcirculatory changes. Localized scleroderma is considered a limited disease. However, in some
cases atrophic and deforming lesions may be observed that hinder the normal development. Literature reports indi-
cate phototherapy as a therapeutic modality with favorable response in cutaneous forms of scleroderma. 
OBJECTIVES - This study had the purpose of assessing the phototherapy treatment for localized scleroderma. 
METHODS - Patients with localized scleroderma were selected for phototherapy treatment. They were classified
according to the type of localized scleroderma and evolutive stage of the lesions. Clinical examination and skin
ultrasound were used to demonstrate the results thus obtained. 
RESULTS - Some clinical improvement was observed after an average of 10 phototherapeutic sessions. All skin
lesions were softer at clinical palpation with scores reduction upon pre and post treatment comparison. The
ultrasound showed that most of the assessed lesions presented a decrease in dermal thickness, and only five
maintained their previous measure. Treatment response was similar regardless of the type of phototherapeutic
treatment employed. 
CONCLUSIONS - The proposed treatment was effective for all lesions, regardless of the phototherapeutic modality
employed. The improvement was observed in all treated skin lesions and confirmed by clinical evaluation and
skin ultrasound.
Keywords: PUVA therapy; Phototherapy; Scleroderma, localized; Ultrasonography; Ultrasound, high-intensity
focused, transrectal
Resumo: FUNDAMENTOS: A esclerodermia é uma doença autoimune caracterizada pela esclerose progressiva do
tecido conjuntivo e alterações da microcirculação. A forma cutânea é considerada uma doença autolimitada. No
entanto, em alguns casos, ocorrem lesões atróficas, deformantes, que dificultam o desenvolvimento normal.
Relatos da literatura apontam a fototerapia como uma modalidade terapêutica com resposta favorável nas for-
mas cutâneas da esclerodermia. 
OBJETIVOS: Este trabalho teve como objetivo avaliar o tratamento da esclerodermia cutânea com fototerapia. 
MÉTODOS: Foram selecionados pacientes com diagnóstico de esclerodermia cutânea para o tratamento com foto-
terapia, os quais foram classificados de acordo com o tipo clínico e o estágio evolutivo das lesões. Utilizou-se o
exame clínico e a ultrassonografia da pele como metodologia para demonstrar os resultados obtidos com o tra-
tamento proposto. 
RESULTADOS: Foi observado o início da melhora clínica das lesões com média de 10 sessões de fototerapia. A pal-
pação clínica mostrou amolecimento em todas as lesões estudadas, com redução nos escores de avaliação esta-
belecidos. No exame de ultrassom, a maioria das lesões avaliadas mostrou diminuição da espessura da derme, e
apenas cinco mantiveram sua medida. Não se observou diferença na resposta ao tratamento de acordo com o
tipo de fototerapia instituída. 
CONCLUSÕES: O tratamento proposto foi efetivo em todas as lesões, independentemente do tipo de fototerapia
realizada. A melhora foi observada em todas as lesões tratadas e comprovada pela avaliação clínica e pelo exame
de ultrassom da pele. 
Palavras-chave: Esclerodermia localizada; Fototerapia; Terapia PUVA; Ultrassom focalizado transretal de alta
intensidade; Ultrassonografia 
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INTRODUCTION
Scleroderma is a chronic autoimmune disease,
characterized by progressive sclerosis of the connecti-
ve tissue and microcirculatory changes.  1, 2 The aetio-
logy of the disease is not yet elucidated. In its patho-
genesis there is damage to the vascular endothelium,
with inflammatory and immunologic activation, lea-
ding to an increased synthesis of collagen and other
proteins of the extracellular matrix. 3
Localized scleroderma is an auto-limited disea-
se and the superficial forms resolve in months or
years, leaving few or no sequelae. 4 However, in ten
percent of the cases there is the development of
atrophic, deforming lesions that delay or hinder the
normal development. 5 This dermatosis can be classi-
fied according to clinical types, as follows:  morphea
scleroderma, in drops, fronto-parietal “en coup de
sabre” with or without facial hemi atrophy (Parry-
Romberg Syndrome), linear or segmentary, deep (sub-
cutaneous), generalized and pan-sclerotic of child-
hood. 1
The clinical aspect presents with two phases of
development. At the beginning the lesions are erythe-
matous or violaceous macules, with smooth surface
and white-yellowish center, which progressively beco-
me depressed and hardened. There is a surrounding
erythematous or sometimes violaceous halo, called
lilac ring. At this stage, called inflammatory, the pin-
ching of the skin at palpation is difficult. The lesion
progresses with a white-ivory color on the central,
atrophic area, surrounded by a sclerotic plaque. This
is called the stage of stable disease. 2, 6, 7
There is no consensus in terms of the efficacy of
the therapeutic modalities used. The improvement
associated with many medications might result from
the normal progress of the disease. Controlled, ran-
domized, well performed studies are rare. 1, 5 Reports
from the literature indicate that phototherapy is a the-
rapeutic modality with favourable response on the
cutaneous forms of scleroderma. 2,5,8,9 Phototherapy,
due to its immunosuppressant effect, inhibits the col-
lagen production and induces an increased synthesis
of collagenase. 10
The objective of this study was to assess the
treatment of cutaneous scleroderma with photothera-
py. The clinical examination and the ultrasound were
used as the methodology to demonstrate the results
achieved with the proposed treatment. 
MATERIAL AND METHODS
During the year 2007, 11 patients with diagno-
sis of cutaneous scleroderma were selected for the
treatment with phototherapy. 
In terms of sex distribution, seven patients
(64%) were women and four (36%) were men, nine
(82%) patients were white and two (18%) had dark
skin. In terms of age, two (18%) were on the age brac-
ket 1-9 years, five (46%) on the 10-19 years and four
(36%) on the 20-29 years.  
These patients were classified according to the
type of cutaneous scleroderma and the evolutive stage
of the lesions: inflammatory or stable. In total 17
lesions of scleroderma were studied, as patients num-
ber six and nine had two lesions each. From patient
number eight, with linear type lesion, two distinct pla-
ces were analysed. From patient number three, with
the generalized form, four places were considered for
analysis due to the extension of the disease. 
The group had eight lesions with the cutaneous
morphea form (47%), five with the linear form (29%)
and four with the generalized form of cutaneous scle-
roderma (24%). In relation to the evolutive stage, the
distribution consisted of eight (48%) lesions on the
inflammatory stage and nine (52%) on the stable
stage.  
The types of phototherapy chosen for this study
were systemic PUVA, topical PUVA and narrow band
UVB. Each patient was submitted to only one type of
phototherapy (described above) according to age, cli-
nical condition, location and extension of the derma-
tosis. In order to execute the treatment safely, all
patients were subjected to the following laboratory
exams, according to the type of phototherapy: hemo-
gram, hepatic transaminases, creatinine, urea, ANF,
pregnancy test for the women and ophthalmologic
examination (fundoscopy). 11
The lesions were assessed before and after
treatment by clinical palpation, performed by the aut-
hor herself, looking for resistance to pinching or skin
hardening. This cutaneous folding was judged in a
scale rating from zero (no sclerosis, normal folding),
to three (severe sclerosis, no folding) as described by
Rook et al, in 1992.12
The group underwent ultrasound examination
of the skin, aiming at measuring the dermis thickness
before the treatment and at the end of the 12th week
of phototherapy. Whenever possible both the area
compromised by the disease and the contra lateral
area of normal skin were assessed. The device used in
the study was the high frequency ultrasound Toshiba
Aplio XG with multifrequency transdutor multifre-
quencial from 7 to 14 MHz for better defining the skin
structures. 
RESULTS
With an average of 10 sessions of phototherapy
the lesions started to have some clinical improve-
ment. The clinical palpation showed softening of all
the studied lesions, both the inflammatory and the
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stable ones, with a reduction of the scores when pre
and post treatments were compared. On table 1 it can
be seen that the sum of the pre-treatment scores was
23 points. The sum of post treatment scores was 11
points. As such, the difference between the initial and
final values was 12 points, indicating a decrease of
52% of the punctuation in terms of analysis of clinical
improvement.  On table 2 it can be observed that all
the lesions had a decrease of the scores post treat-
ment.  The sum of the pre-treatment scores was 27
points and the sum of the scores post treatment was
14 points. When both scores are compared the diffe-
rence was 13 points, showing that there was a reduc-
tion of 48% of the punctuation when assessing the cli-
nical improvement.
At ultrasound examination most lesions asses-
sed had a decrease of the dermal thickness and only
some retained its original measure (Tables 3 and 4).
The result of the ultrasound on the contra lateral side
was considered as the normal dermal thickness for
each patient.  This data was used to assess the results
with the ultrasound after the treatment, comparing
with the value of the initial exam (Figures 1, 2, 3 and
4). In some patients with extensive lesions two to four
measures were obtained on the same lesion. On
patient number three, with the generalized form, it
was not possible to do the contra lateral ultrasound as
there was no normal skin. The average values of der-
mal thickness at this location, based on the personal
experience of the radiologist, were considered. 
There was no difference in relation to treat-
ment response in terms of the type of phototherapy
used.
The lesions studied on the inflammatory stage
had, at the initial ultrasound, higher dermal thickness
than normal skin (Table 3). There was a decrease of
the thickness of all lesions with the treatment, except
from lesion number six of patient number three,
which remained unaltered. On the second last
column of the table there is the value of the decrease
Patient Type of Scleroderma Lesion Place Pre-treatment (1) Post-treatment (2)
1 Morphea 1 Left thigh 3 2
2 Morphea 2 Left infrascapular region 3 1
3 Generalized 3 Dorsum, left 3 1
4 Dorsum, right 3 2
5 Right calf 3 2
6 Left calf 3 2
4 Morphea 7 Right hypochondrium 2 1
5 Morphea 8 Cervical, left 3 0
TABLE 1: Assessment of the clinical response obtained by skin palpation of the inflammatory lesions of 
localized scleroderma treated with phototherapy 
Dermatology Clinic – Departament of Medicine of the Santa Casa de São Paulo, January to December de 2007.
(1) Total score = 23
(2) Total score = 11
Patient Type of Scleroderma Lesion Place Pre-treatment (1) Post-treatment (2)
6 Morphea 9 Right forearm 3 1
10 Right arm 3 1
7 Linear 11 Left upper limb 3 2
8 Linear 12 Right lower limb 3 1
13 Right buttock 3 2
9 Morphea 14 Right thigh 3 2
15 Right leg 3 2
10 Linear 16 Frontal area 3 1
11 Linear 17 Left forearm 3 2
TABLE 2: Assessment of the clinical response obtained by skin palpation of the stable lesions of localized 
scleroderma treated with phototherapy 
Clínica de Dermatologia – Departamento de Medicina da Santa Casa de São Paulo, janeiro a dezembro de 2007.
(1) Escore total = 27
(2) Escore total = 14
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of the thickness in millimetres of each treated lesion,
and on the last column the percentage of the decrea-
se of the dermal thickness in each lesion. On table 4
(lesions on stable stage) it is observed that the values
of the contra lateral ultrasound, considered as normal
skin, had highest measures than the studied lesions.
All lesions had lower thickness than normal skin befo-
re treatment, confirming the stable stage of the disea-
se.   The post treatment ultrasound showed that in
four measures (patients seven, eight and nine) there
was no alteration, retaining the thickness of the initial
exam. However, there was decrease of dermal thick-
ness in at least one measure of each patient, when
comparing ultrasounds pre and post treatment (last
column of table 4). 
No acute side effect like itch, erythema or burns
was observed.  
Patient Type of Type of pho- Lesion Place US pre US post USG(1) con- Decrease % of im-
scleroderma totherapy (mm) (mm) tralate (mm) in mm(2) provement
1 Morphea PUVA 1 Proximal thigh 3,7 2,1 1,6 1,6 76
Distal thigh 3,4 2,6 1,6 0,8 44
2 Morphea Topical PUVA 2 Border of the 1,7 1,3 1,3 0,4 100
lesion
Center of the 2,6 2,3 1,4 0,3 25
lesion
3 Generalized Narrow  3 Dorsum, left 5,5 4,0 # (3) 1,5 60
band UVB
4 Dorsum, right 4,5 4,2 # (3) 0,3 20
5 Right calf 2,8 2,1 # (1,5) 0,7 54
6 Left calf 2,3 2,3 # (1,5) - 0
4 Morphea Topical PUVA 7 Border of the 1,5 1,4 1,0 0,1 20
lesion
Center of the  1,2 1,0 1,0 0,2 100
lesion
5 Morphea Topical PUVA 8 Cervical, left 1,8 1,4 1,4 0,4 100
TABLE 3: Type of phototherapy used and assessment of the response by skin ultrasound (in millimeters) of the
inflammatory lesions of localized scleroderma treated with phototherapy 
Dermatology Clinic – Departament of Medicine of the Santa Casa de São Paulo, January to December de 2007.
(1) Normal skin 
(2) Millimeters
Patient Type of Type of Lesion Place US pre US post US(1) con- Decrease
scleroderma phototherapy (mm) (mm) tralate (mm) in mm(2)
6 Morphea Topical PUVA 9 Forearm 1,3 0,6 1,4 0,7
10 Arm 1,0 0,8 1,4 0,2
7 Linear Narrow band 11 Wrist 1,0 0,9 1,6 0,1
UVB Forearm 0,7 0,7 1,0 -
8 Linear Narrow band 12 Proximal thigh 1,2 1,2 1,3 -
UVB Distal thigh 1,0 0,9 1,2 0,1
13 Buttock 1,0 1,0 1,2 -
9 Morphea PUVA 14 Thigh 1,6 1,6 2,2 -
15 Leg 1,2 1,1 1,9 0,1
10 Linear Topical PUVA 16 Frontal area 0,8 0,6 1,3 0,2
11 Linear Narrow band 17 Forearm 1,2 1,1 1,5 0,1
UVB
TABLE 4: Type of phototherapy used and assessment of the response by skin ultrasound (in millimeters) of the
stable lesions of localized scleroderma treated with phototherapy 
Dermatology Clinic – Departament of Medicine of the Santa Casa de São Paulo, January to December de 2007.
(1) Normal skin
(2) Millimeters
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DISCUSSION
Phototherapy contributes to the improvement
of scleroderma through three main actions, which are:
immunomodulation of inflammation, stimulus to col-
lagen synthesis and T lymphocytes apoptosis. 13-17
The results of the clinical and ultrasound eva-
luation after treatment with phototherapy showed
improvement of the localized sclerodema lesions in
all patients. The clinical palpation showed softening
of the lesions. The ultrasound contributed to comple-
ment this assessment. 
In terms of clinical assessment, tables 1 and 2
show a reduction of the scores of 52% and 48% res-
pectively, an indication that both the inflammatory
and the stable lesions responded to treatment with
phototherapy. This result demonstrates that even in
more advanced lesions, with sclerosis and atrophy
already installed, the treatment contributed by softe-
ning the skin. 
When analysing the types of lesions, different
responses in relation to the type of phototherapy
employed could not be not seen. The restrict number
of lesions studied, in both groups, did not allow an
evaluation of the type of phototherapy indicated.
Literature studies show that phototherapy using syste-
mic or topical PUVA or narrow band UVB were effecti-
ve in the treatment of localized scleroderma. 2,5,8,9 The
FIGURE 1: Morphea scleroderma – inflammatory stage 
(patient number 2). Pre-treatment with phototherapy; B. Morphea
scleroderma - inflammatory stage (patient number 
2). Post-treatment with phototherapy
FIGURE 2: A. Morphea scleroderma – inflammatory stage 
(patient number 2). Pre-treatment. High frequency ultrasound -
Dermis: 1, 7 millimeters; B. Morphea scleroderma – inflammatory
stage (patient number 2). Post-treatment. High frequency ultra-
sound- Dermis: 1, 3 millimeters; C. Morphea scleroderma –
inflammatory stage (patient number 2). Contralateral. High 
frequency ultrasound - Dermis: 1,3 millimeters
A A
B
C
B
ABNORMAL MARGIN
CONTRALATERAL NORMAL
MARGIN
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proper indication of each type of phototherapy might
also have contributed to the good clinical response
showed by the patients.   
The results from the ultrasound examination
were divided in two groups according to the classifica-
tion of the evolutive stage of the lesions (Table 3 and
4). On table 3 it was observed that, in all inflammato-
ry lesions, the contra lateral side (considered normal)
had a dermal thickness lower that the involved site.
After treatment all lesions were less thick, varying
from 20 to 100%. Only one patient (number three)
had one lesion, among the four studied, with no chan-
ge in millimetres at the ultrasound examination. This
case demonstrates that phototherapy can have diffe-
rent responses even on the same patient. It is interes-
ting to note that the clinical assessment of this lesion
had an initial score of three points and, after treat-
ment; the final score was two points, indicating skin
softening.  This patient number three, with generali-
zed cutaneous scleroderma in the inflammatory stage,
was sent by the endocrinology outpatients’ clinic
because she could no longer inject the subcutaneous
insulin due to the skin hardening. After five weeks of
phototherapy the skin started to soften and it was
necessary to reduce the dose of insulin as the cuta-
neous absorption of the drug increased. Maybe a lon-
ger treatment is needed so that the generalized, more
severe forms, respond to phototherapy in a more uni-
form way. On table 4, the stable lesions had lower
thickness that the contra lateral measures, considered
normal. With the treatment there was an even more
pronounced decrease of the dermal thickness in seven
measures, and in four the measures remained unalte-
red when assessed by the ultrasound. However, all
lesions had a clinical improvement, as observed by the
lowering of the scores. In this group (stable lesions)
the score dropped 48%. We cannot state that the pho-
totherapy was not effective on the stable lesions. The
decrease of the thickness of the lesions with photothe-
FIGURE 3: A. Linear scleroderma– stable stage (patient number 8 /
lesion 12). Pre-treatment with phototherapy; B. Linear scleroder-
ma– stable stage (patient number 8 / lesion 12). Post-treatment
with phototherapy
FIGURE 4: A. Linear scleroderma– stable stage (patient number 8 /
lesion 12). Pre-treatment. High frequency ultrasound - dermis: 1, 0
millimeters; B. Linear scleroderma– stable stage (patient number 8
/ lesion 12). Post-treatment. High frequency ultrasound - dermis:
0, 9 millimeters; C. Linear scleroderma– stable stage (patient num-
ber 8 / lesion 12). Contralateral. High frequency ultrasound - der-
mis: 1,2 millimeters
A B A
B
C
LOWER LATERAL REGION OF THE RIGHT THIGH
LOWER REGION OF THE RIGHT THIGH
NORMAL
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rapy is probably explained by its own mechanism of
action in scleroderma. As already reported, the synt-
hesis and activity of collagenase is stimulated by pho-
totherapy. 17 The increment of this enzyme might have
contributed to the occurrence of the existing collagen
degradation with subsequent remodelling. It was
clearly demonstrated that the results obtained by the
skin ultrasound depend on the evolutive stage of the
localized scleroderma lesions.
The inclusion of a control group on the metho-
dology would give even more value to the results
obtained. 
CONCLUSIONS
The proposed treatment was effective in all
lesions, regardless of the type of phototherapy used.
Improvement was observed in all treated lesions and
confirmed by clinical assessment and ultrasound exa-
mination of the skin. 
Our results encourage us to continue our work,
including a control group, improving the scientific
methodology more and more.  ❑
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